New incident report
Incident Report Number: 2023-4537
Registrant Reference Number: ProPharma Group case #: 2023SCPC00071142-1
Registrant Name (Full Legal Name no abbreviations): Syngenta Canada Inc.
Address: 140 Research Lane, Research Park
City: Guelph
Prov / State: Ontario
Country: Canada
Postal Code: N1G4Z3
Human
Country: CANADA
Prov / State: ONTARIO
PMRA Registration No. 27517 PMRA Submission No. EPA Registration No. Unknown
Product Name: ALLEGRO 500F AGRICULTURAL FUNGICIDE
PMRA Registration No. PMRA Submission No. EPA Registration No.
Product Name: ALTACOR
Yes
Units: L/ha
Site: Agricultural-Outdoor/Agricole-extérieur
Préciser le type: Apples
Unknown
Other
Sex: Male
Age: >19 <=64 yrs / >19 <=64 ans
System
Unknown / Inconnu
Yes
No
Occupational
Contact with treated area
Amount of time between application and contact 3
Day(s) / Jour(s)
What was the activity? Thinning fruit
Long-sleeve shirt
Long pants
Chemical resistant gloves
Skin
Unknown / Inconnu
>1 wk <=1 mo / > 1 sem < = 1 mois
2023SCPC00071142-1- The reporter, a farmer, indicates exposure to a pesticide containing the active ingredient fluazinam. Approximately four weeks before the day of initial contact with the registrant, the reporter indicated their apple orchards were sprayed with the pesticide, then a three-day waiting period was observed before the orchard was entered and worked daily for another ten days. Approximately two weeks before the day of initial contact with the registrant, the reporter indicated their apple orchards were sprayed with the pesticide, then a three-day waiting period was observed before the orchard was entered and worked daily for approximately seven days. One day before the day of initial contact, a worker who had been in the orchard after both applications, contacted the reporter indicating his face was swollen, throat was swollen, and his eyes were swollen shut. The worker was immediately taken to an emergency department where he was treated with intravenous steroids and Benadryl. The worker was observed for an hour then discharged after being prescribed several days of oral Benadryl. On the day of initial contact, the reporter indicated the worker's face still had a small amount of swelling which the doctor had previously indicated should subside after a few days. The reporter was not available on follow-up call four days later. On follow-up five days later the reporter stated all of the patient's symptoms had resolved. No additional information is available.
Minor